{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["47(1)"],"submitter":["Altermatt A"],"pubmed_abstract":["<h4>Objective</h4>To estimate the proportion of Victorians infected with COVID-19 in January 2022.<h4>Methods</h4>Between 11-19 February 2022 we conducted a nested cross-sectional survey on experiences of COVID-19 testing, symptoms, test outcome and barriers to testing during January 2022 in Victoria, Australia. Respondents were participants of the Optimise Study, a prospective cohort of adults considered at increased risk of COVID-19 or the unintended consequences of COVID-19-related interventions.<h4>Results</h4>Of the 577 participants, 78 (14%) reported testing positive to COVID-19, 240 (42%) did not test in January 2022 and 91 of those who did not test (38%) reported COVID-19-like symptoms. Using two different definitions of symptoms, we calculated symptomatic (27% and 39%) and asympto"],"journal":["Australian and New Zealand journal of public health"],"pagination":["100007"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9874236"],"repository":["biostudies-literature"],"pubmed_title":["Estimating the proportion of Victorians infected with COVID-19 during the Omicron BA.1 epidemic wave of January 2022 in Australia."],"pmcid":["PMC9874236"],"pubmed_authors":["Altermatt A","Gibney KB","Lee Wilkinson A","Heath K","Saich F","Scott N","Sacks-Davis R","Young K","Stoove M","Hellard M"],"additional_accession":[]},"is_claimable":false,"name":"Estimating the proportion of Victorians infected with COVID-19 during the Omicron BA.1 epidemic wave of January 2022 in Australia.","description":"<h4>Objective</h4>To estimate the proportion of Victorians infected with COVID-19 in January 2022.<h4>Methods</h4>Between 11-19 February 2022 we conducted a nested cross-sectional survey on experiences of COVID-19 testing, symptoms, test outcome and barriers to testing during January 2022 in Victoria, Australia. Respondents were participants of the Optimise Study, a prospective cohort of adults considered at increased risk of COVID-19 or the unintended consequences of COVID-19-related interventions.<h4>Results</h4>Of the 577 participants, 78 (14%) reported testing positive to COVID-19, 240 (42%) did not test in January 2022 and 91 of those who did not test (38%) reported COVID-19-like symptoms. Using two different definitions of symptoms, we calculated symptomatic (27% and 39%) and asympto","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jan","modification":"2025-04-19T13:33:14.721Z","creation":"2025-02-18T23:37:05.93Z"},"accession":"S-EPMC9874236","cross_references":{"pubmed":["36706552"],"doi":["10.1016/j.anzjph.2022.100007"]}}